Impact of the Frankfurt HAE therapy protocol on health-related quality of life (HRQoL) in 50 patients with hereditary angioedema (HAE)

被引：0
|
作者：
Wolfhart, K. [1 ]
Martinez-Saguer, I [1 ]
Rusicke, E. [1 ]
Aygoeren-Puersuen, E. [1 ]
Klingebiel, T. [1 ]
机构：
[1] Johann Wolfgang Goethe Univ Hosp, Frankfurt, Germany
来源：
ALLERGY | 2009年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
493
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [1] Impact Of The Frankfurt HAE Therapy Protocol On Health-Related Quality Of Life (HRQoL) In 50 Patients With Hereditary Angioedema (HAE)
    Kreuz, W.
    Martinez-Saguer, I.
    Rusicke, E.
    Aygoeren-Puersuen, E.
    Klingebiel, T.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S116 - S116
  • [2] Relationship Between Angioedema Attacks and Health-Related Quality Of Life Outcomes In Patients With Hereditary Angioedema (HAE)
    Dayno, Jeff
    Miller, Dave P.
    Hautamaki, Emily
    Newcomer, Scott
    Fitts, David
    Lumry, William R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB33 - AB33
  • [3] Health-Related Quality of Life (HRQoL) in Pediatric Patients with Hereditary Angioedema (HAE) Receiving Lanadelumab: Exploratory Results From the SPRING Study
    Watt, Maureen
    Maurer, Marcus
    Lumry, William
    Li, H. Henry
    Aygoeren-Puersuen, Emel
    Busse, Paula
    Jacobs, Joshua
    Nurse, Christina
    Yu, Ming
    Romanus, Dorothy
    Devercelli, Giovanna
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB139 - AB139
  • [4] Development of a New Tool for Assessing Health-Related Quality of Life (QoL) in Patients with Hereditary Angioedema (HAE): The United States HAE Association (HAEA)-QoL
    Christiansen, Sandra C.
    Busse, Paula J.
    Birmingham, Janette
    Banerji, Aleena
    Lumry, William R.
    Zuraw, Bruce L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB51 - AB51
  • [5] Lanadelumab improves health-related quality of life in patients with hereditary Angioedema (HAE): findings from the HELP study
    Longhurst, Hilary
    Lumry, William
    Weller, Karsten
    Magerl, Markus
    Lu, Peng
    Jain, Gagan
    Lewis, Hannah
    Maurer, Marcus
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (11): : 1524 - 1525
  • [6] IMPACT OF HEREDITARY ANGIOEDEMA (HAE) ATTACKS ON QUALITY OF LIFE AND ACTIVITIES OF DAILY LIVING
    Busse, P.
    Caballero, T.
    van Kooten, S.
    Danese, S.
    Goga, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S26 - S26
  • [7] QUALITY OF LIFE OF HEREDITARY ANGIOEDEMA (HAE) PATIENTS WITH DEPRESSION OR ANXIETY RECEIVING LANADELUMAB
    Craig, T.
    Soteres, D.
    Anderson, J.
    Paes, K.
    Hao, J.
    Hashemi, L.
    Watt, M.
    Juethner, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S25 - S25
  • [8] Determinants of health related quality of life (HRQoL) in adult patients with hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE)
    Lluncor, Marina
    Lamacchia, Donatella
    Hernanz, Adriana
    Pedrosa, Maria
    Alvez, Ana
    Cabanas, Rosario
    Prior, Nieves
    Caballero, Teresa
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB266 - AB266
  • [9] Development of a disease specific health-related quality of life (HRQOL) questionnaire in adults with hereditary angioedema due to C1 inhibitor deficiency (HAE) in Spain (first phase)
    Prior, N
    Remor, E
    Serrano, CL
    González, T
    Cimbollek, S
    Guilarte, M
    Hernandez, D
    Tejedor, M
    Rubio, M
    Caballero, T
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S270 - S270
  • [10] Improved health-related quality of life in pediatric patients with hereditary angioedema (HAE): a phase 3 study of C1 inhibitor for attack prevention
    Martinez-Saguer, I
    Soteres, D.
    Van Leerberghe, A.
    Herrera, E. M.
    Devercelli, G.
    Vardi, M.
    Christensen, J.
    ALLERGY, 2018, 73 : 718 - 718
12345